epiSEEK® Infancy and Childhood Epilepsy Panel (71 Genes)
Courtagen’s Infancy and Childhood Epilepsy Panel provides extensive genetic analysis and clinical interpretation of data generated by the complete sequencing of genes associated with early onset epilepsy and seizure disorders.
Knowing the genetic basis of a child’s epilepsy is valuable for obtaining a definitive diagnosis, estimating prognosis, determining recurrence risks, and guiding treatment choices. In many cases, the precise genetic diagnosis can be important in therapy selection.This test includes syndromic and nonsydromic disorders associated with epilepsy such as Angelman, Angelman-like syndromes, Rett, atypical Rett syndromes, Cerebral folate deficiency, Creatine deficiency syndromes, Mowat-Wilson syndrome, West syndrome, Ohtahara syndrome, Early onset epileptic encephalopathy, Idiopathic generalized epilepsy, Benign familial neonatal seizures (BFNS), Familial infantile myoclonic epilepsy (FIME), Juvenile myoclonic epilepsy, Progressive myoclonic epilepsy, Epilepsy with behavioral and learning disorder.
Product Information Sheets:epiSEEK® Infancy and Childhood Epilepsy Panel (71 genes)
Addendum: epiSEEK® Infancy and Childhood gene list (71 genes)
Courtagen's Unmatched Customer SupportTurn Around Time:4-6 weeks. Results are delivered in weeks, not months.
Saliva Sample: DNA for sequencing is reliably extracted from a single saliva sample. No blood draw or muscle biopsy required. (Whole blood and tissue are accepted, as requested.)
Insurance Assistance:Courtagen works with patients, physicians, and insurance carriers to pre-approve each test. Courtagen will bill the insurance company, and is willing to handle an appeal process as needed.
Courtagen Care Financial Program:For qualified patients, the Courtagen Care Financial Program can help limit out–of–pocket expenses to $0, $50, or $100 per test.
Online Portal:A secure physician online portal is available for ordering genetic tests and accessing patient reports when completed.
Genetic Counselors:Available to address your questions regarding Courtagen test results.
Clinical Experience:Courtagen’s Medical Director, Laboratory Director, and variant science team have over 25 years of experience in the treatment and genetic interpretation of neurological and metabolic disorders.
Reports:Utilizing Courtagen’s customized Ziphyr® informatics pipeline and thorough clinical evaluation, each report is provided in a concise format with interpretation and recommendations for consideration.